Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CHRN | UNFI |
|---|---|---|
| Price | $18.89 | $44.93 |
| Change today | ▲ 1.55% | ▲ 0.90% |
| Market cap | $2.75B | $2.71B |
| Return, 3 months | +7.8% | -4.9% |
| Return, year to date | +118.6% | +33.4% |
| Return, 1 year | +244.0% | +8.6% |
| P/E (TTM) | -52.5 | 33.5 |
| P/B | 15.3 | 1.7 |
| P/E percentile vs own 5y | 3rd | 95th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +69.4% | +16.5% |
| Analyst buy share | 100% | 25% |
| RSI (14) | 43 | 44 |
| 30-day volatility | 84.3% | 33.6% |
| Max drawdown, 1 year | -40.4% | -27.0% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
